Okay you clearly haven't spent time working in healthcare because no doctor spends 5 hours on a patient every week, the protocol won't require it in any case.
The direct cost of managing a patient with duchenne is close to 20k/year, including medications, hospital visits, clinic visits
When you're thinking about clinical trials, all that's required on top of that is probably a fortnightly blood test, weekly drug injection, and those PUL2 assessments maybe every month, a few MRI scans, and questionnaires. Clinic visits will be more frequent, say once a month, but your costs won't blow out to 150k per patient.
I cant see how adding a few more scans, blood tests, and clinic visits will cost more than double their routine medical costs inclusive of medications.
40k * 75 = 3m USD = 4.5m AUD is a reasonable estimate. Easily achievable with a small cap raise or exercise of options.
ANP Price at posting:
14.5¢ Sentiment: None Disclosure: Not Held
(20min delay)